Tatva Chintan Pharma Chem Results Earnings Call for Q2FY24
Conference Call with Tatva Chintan Pharma Chem Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.02-11-2023
02-11-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the Quarter and Half Year ended 30 September 2023.02-11-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On 30 September 2023
Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Half Year Ended On 30 September 202302-11-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of The Board Meeting Held On 02.11.2023
Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('SEBI Listing Regulations'), we enclose herewith the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30 September 2023. The said Results were reviewed and recommended by Audit Committee and approved by the Board of Directors of the Company in their respective meetings held on 02 November 2023. Further, we enclose herewith Limited Review Report issued by M/s. NDJ & Co., Chartered Accountants, (Firm Registration No. 136345W), Statutory Auditors of the Company as required under Regulation 33 of SEBI Listing Regulations. The above information shall be made available on the website of the Company at www.tatvachintan.com. The Board meeting commenced at 11:45 A.M. and concluded at 03:35 P.M.02-11-2023
Tatva Chintan Pharma Share Price Live blog for 01 Nov 2023
Tatva Chintan Pharma stock price went down today, 01 Nov 2023, by -1.72 %. The stock closed at 1505.2 per share. The stock is currently trading at 1479.35 per share. Investors should monitor Tatva Chintan Pharma stock price closely in the coming days and weeks to see how it reacts to the news.01-11-2023
Tatva Chintan Pharma Share Price Live blog for 31 Oct 2023
Tatva Chintan Pharma stock price went down today, 31 Oct 2023, by -0.34 %. The stock closed at 1505.2 per share. The stock is currently trading at 1500.1 per share. Investors should monitor Tatva Chintan Pharma stock price closely in the coming days and weeks to see how it reacts to the news.31-10-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Earnings Call post announcement of financial results of the Company for the quarter and half year ended 30 September 2023, is scheduled on Thursday, 02 November 2023 at 05:00 p.m. (IST). The Call is hosted by ICICI Securities and an invite in this regard is attached for your information and records. The above information is also being made available on the website of the Company at https://www.tatvachintan.com/.23-10-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 02.11.2023
Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 ,inter alia, to consider and approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and half year ended 30 September 2023. Further, in accordance with the Company''s Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ''''designated persons'''' regarding the closure of the Trading Window for trading in the Company''s equity shares from 01 October 2023 till the expiry of 48 hours from the date the said financial results are made public. The above information is also being made available on the website of the Company at www.tatvachintan.com.20-10-2023
Tatva Chintan Pharma Chem Ltd - 543321 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201806-10-2023
Buy Tatva Chintan Pharma Chem; target of Rs 2000: ICICI Securities
ICICI Securities is bullish on Tatva Chintan Pharma Chem recommended buy rating on the stock with a target price of Rs 2000 in its research report dated September 27, 2023.28-09-2023